Biosphere Wins $21 Million Pentagon Biomanufacturing Contract
The U.S. Department of Defense awarded Biosphere $21 million to build a facility designed to produce about 100 tons of chemicals annually.
FlyMarshall Newsroom1 min read
Photo: Breaking Defense
Biosphere received a $21 million U.S. Department of Defense contract to build a biomanufacturing facility. The company plans to use genetically engineered microorganisms to make chemicals for industrial and military applications.
Key details
- The facility is designed for 20,000 liters of production capacity.
- Biosphere projects annual output of about 100 tons of chemicals.
- The company expects to commission the facility in the fourth quarter of 2027.
- Potential products mentioned include material that hardens sand for helicopter landing areas and polymer-bonded explosives; these were examples, not confirmed production items.
Biosphere plans a facility with 20,000 liters of production capacity.
Why it matters
The planned facility would give the Defense Department a domestic production site for selected chemicals using microbial manufacturing. Biosphere’s CEO said the company had discussed two or three fine chemicals that could fit the facility and government priorities, but did not identify them.
What happens next
Biosphere is targeting commissioning in the fourth quarter of 2027, when the facility could begin its planned production. Which applications will the company’s first chemicals serve?
More stories
Navy Leaders Warn of Years-Long Ship Maintenance Demand
Lockheed Martin Redirects GMLRS Rocket to Moving Target During Army Test
Bombardier and BAE Systems Plan Canadian Air-Combat Collaboration
Alaska Airlines Plans Anchorage–Tokyo Narita Route for 2027
American Airlines Dispatchers and Operations Specialists Approve New Contract
